Exploring the Role of New Adjuvant Matinev and Surgical Optimizations in Gastrointestinal Stromal Tumors

This chapter explores the role of adjuvant matinev in Gastrointestinal Stromal Tumors (GIST), focusing on its use in surgery facilitation, mutation-based therapy selection, and dosing considerations for different mutations. It also delves into the criteria for utilizing adjuvant matinev in high-risk recurrence cases.